Thus, results showing increased serum visfatin levels during pregnancies complicated by GDM or IUGR [15, 17], as well as our results indicating that hCG increased visfatin levels in placenta cells, lead to a potential role of visfatin in the prediction and compensation or generation of symptoms of pregnancy disorders. The gene discussed is NAMPT; the disease is gestational diabetes.